NLS Other Assets from 2010 to 2024

NLSPW Stock  USD 0.01  0  11.11%   
NLS Pharmaceutics Other Assets yearly trend continues to be fairly stable with very little volatility. Other Assets will likely drop to 0.86 in 2024. During the period from 2010 to 2024, NLS Pharmaceutics Other Assets regression line of quarterly data had mean square error of 5.7 B and geometric mean of  4,007. View All Fundamentals
 
Other Assets  
First Reported
2010-12-31
Previous Quarter
0.9
Current Value
0.86
Quarterly Volatility
127 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NLS Pharmaceutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NLS Pharmaceutics' main balance sheet or income statement drivers, such as Interest Income of 681.3 K, Depreciation And Amortization of 9.8 K or Interest Expense of 137.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NLS financial statements analysis is a perfect complement when working with NLS Pharmaceutics Valuation or Volatility modules.
  
Check out the analysis of NLS Pharmaceutics Correlation against competitors.

Latest NLS Pharmaceutics' Other Assets Growth Pattern

Below is the plot of the Other Assets of NLS Pharmaceutics AG over the last few years. It is NLS Pharmaceutics' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NLS Pharmaceutics' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Slightly volatile
   Other Assets   
       Timeline  

NLS Other Assets Regression Statistics

Arithmetic Mean173,474
Geometric Mean4,007
Coefficient Of Variation73.19
Mean Deviation115,648
Median260,210
Standard Deviation126,969
Sample Variance16.1B
Range260.2K
R-Value(0.82)
Mean Square Error5.7B
R-Squared0.67
Significance0.0002
Slope(23,233)
Total Sum of Squares225.7B

NLS Other Assets History

2024 0.86
2023 0.9
2020 1.0

About NLS Pharmaceutics Financial Statements

NLS Pharmaceutics investors use historical fundamental indicators, such as NLS Pharmaceutics' Other Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NLS Pharmaceutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Assets 0.90  0.86 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NLS Stock Analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.